HeartSciences (HSCS) Net Cash Flow Growth (1y) (2022 - 2026)
HeartSciences (HSCS) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | -54.17% |
| 10 | HeartSciences | 6.51 Mn | 4.81 Mn | - | -16.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -16.14% |
| Oct 31, 2025 | -192.41% |
| Jul 31, 2025 | 215.41% |
| Apr 30, 2025 | -18.09% |
| Jan 31, 2025 | -120.86% |
| Oct 31, 2024 | 39.51% |
| Jul 31, 2024 | -35.31% |
| Apr 30, 2024 | -369.10% |
| Jan 31, 2024 | 709.28% |
| Oct 31, 2023 | 60.26% |
| Jul 31, 2023 | -132.34% |
| Apr 30, 2023 | 34.02% |
| Jan 31, 2023 | -219.54% |
| Oct 31, 2022 | -55.79% |
| Jul 31, 2022 | 567.50% |